Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Cash from Investing Activities (2016 - 2026)

Ocular Therapeutix has reported Cash from Investing Activities over the past 14 years, most recently at -$4.7 million for Q1 2026.

  • For Q1 2026, Cash from Investing Activities fell 141.18% year-over-year to -$4.7 million; the TTM value through Mar 2026 reached -$14.6 million, down 392.55%, while the annual FY2025 figure was -$11.9 million, 822.36% down from the prior year.
  • Cash from Investing Activities for Q1 2026 was -$4.7 million at Ocular Therapeutix, down from -$2.8 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$89000.0 in Q3 2024 and troughed at -$6.0 million in Q3 2025.
  • A 5-year average of -$1.6 million and a median of -$794000.0 in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: surged 92.45% in 2024 and later tumbled 6633.71% in 2025.
  • Year by year, Cash from Investing Activities stood at -$2.2 million in 2022, then soared by 78.65% to -$459000.0 in 2023, then skyrocketed by 55.99% to -$202000.0 in 2024, then tumbled by 1305.45% to -$2.8 million in 2025, then tumbled by 64.21% to -$4.7 million in 2026.
  • Business Quant data shows Cash from Investing Activities for OCUL at -$4.7 million in Q1 2026, -$2.8 million in Q4 2025, and -$6.0 million in Q3 2025.